Cochrane Abstracts
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Real‐world Prognosis of Eyes With Diabetic Macular Oedema Receiving Treatment With Vascular Endothelial Growth Factor (VEGF) Inhibitors." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435846/all/Real‐world_prognosis_of_eyes_with_diabetic_macular_oedema_receiving_treatment_with_vascular_endothelial_growth_factor__VEGF__inhibitors.
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/all/Real‐world_prognosis_of_eyes_with_diabetic_macular_oedema_receiving_treatment_with_vascular_endothelial_growth_factor__VEGF__inhibitors. Accessed January 21, 2025.
Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/all/Real‐world_prognosis_of_eyes_with_diabetic_macular_oedema_receiving_treatment_with_vascular_endothelial_growth_factor__VEGF__inhibitors
Real‐world Prognosis of Eyes With Diabetic Macular Oedema Receiving Treatment With Vascular Endothelial Growth Factor (VEGF) Inhibitors [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 21]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/all/Real‐world_prognosis_of_eyes_with_diabetic_macular_oedema_receiving_treatment_with_vascular_endothelial_growth_factor__VEGF__inhibitors.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Real‐world prognosis of eyes with diabetic macular oedema receiving treatment with vascular endothelial growth factor (VEGF) inhibitors
ID - 435846
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435846/all/Real‐world_prognosis_of_eyes_with_diabetic_macular_oedema_receiving_treatment_with_vascular_endothelial_growth_factor__VEGF__inhibitors
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
